Vivi Kasim

25PUBLICATIONS
21CO-AUTHORS
Cancer diagnosisCancer geneticsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Nov 07, 2025
NFATc1-mediated activation of the pentose phosphate pathway and cell cycle dysregulation collectively drive tumor progression.

Suyang Zhang, Guangyao Xu, Tianyu Cao

|Sep 22, 2025
Publisher Correction: NeuroD1 drives a KAT2A-FDFT1 signaling axis to promote cholesterol biosynthesis and hepatocellular carcinoma progression via histone H3K27 acetylation.

Zheng Wu, Wei Duan, Ying Xiong

|Sep 01, 2025
NeuroD1 drives a KAT2A-FDFT1 signaling axis to promote cholesterol biosynthesis and hepatocellular carcinoma progression via histone H3K27 acetylation.

Zheng Wu, Wei Duan, Ying Xiong

|Aug 28, 2025
Yin Yang 1 (YY1) as a Central Node in Drug Resistance Pathways: Potential for Combination Strategies in Cancer Therapy.

Zhiyan Li, Xiang Jia, Ian Timothy Sembiring Meliala

|Jun 13, 2025
PBX3-HMGCR Axis Promotes Hepatocellular Carcinoma Progression Through Enhancing De Novo Cholesterol Biosynthesis.

Xia Zhang, Li Qiu, Lei Zhang

|Feb 04, 2025
Chromosome Missegregation Triggers Tumor Cell Pyroptosis and Enhances Anti-Tumor Immunotherapy in Colorectal Cancer.

Wei Duan, Rendy Hosea, Lingxian Wang

Pageof 5

Frequent Collaborators

19 joint publications

Shourong Wu

5 joint publications

Rendy Hosea

3 joint publications

Can Huang

2 joint publications

Makoto Miyagishi